Attachment

G1 - NIAID DIR collaborative agreements active between June 1 2016 and Dec 13 2023 Reference# I Agreement Type Effective Date Expiration Dz External Parties *Lead Pl GLAXO WELLCOME, INC. (now GlaxoSmithKline; 2018-0916 CTA - Clinical Trial Agreement 9/3/2020} GSK) Amy Klion 2018-0919 Research Collaboration Agreement 9/19/2018] 9/19/2021]QMENTA [ES] Bibi Bielekova 2018-0932 Research Collaboration Agreement 10/1/2018] 10/1/2023] University of Florida [US] Maureen Goodend 2018-0969 Research Collaboration Agreement 1/29/2019] _1/29/2025|American Gene Technologies International, Inc. Tae Wook Chun Walter Reed Army Institute of Research (WRAIR) (DoD), Walter Reed National Military Medical 2018-0972 Research Collaboration Agreement 2/28/2019} _2/28/2023|Center (WRNMMC) (DoD) Peter Crompton Institute of Microbiology of the Federal Defense 2018-0975 Research Collaboration Agreement 10/1/2018] 10/4/2021] Forces (Institut fur Mikrobiolo Alexander Pletnev Institute of Microbiology of the Federal Defense 2018-0975 Research Collaboration Agreement 10/1/2018] 10/4/2021] Forces (Institut fur Mikrobiolo Alexander Pletnev Institute of Microbiology of the Federal Defense 2018-0975 Research Collaboration Agreement 10/1/2018] 10/4/2021] Forces (Institut fur Mikrobiolo Alexander Pletnev 2018-0978 Gift 10/23/2018] _3/31/2020)Bill & Melinda Gates Foundation (BMGF) 2018-0978 Gift 10/23/2018] _3/31/2020)Bill & Melinda Gates Foundation (BMGF) 2018-1009 Research Collaboration Agreement 10/30/2018] 10/30/2021|Xiamen University [CN] XinZhuan Su 2018-1026 Research Collaboration Agreement 10/15/2018] 10/15/2020|A2 Biotherapeutics 2018-1071 Research Collaboration Agreement 10/30/2018] 10/30/2021] Ohio State University Yongli Xiao 2018-1071 Research Collaboration Agreement 10/30/2018] 10/30/2021] Ohio State University Yongli Xiao 2018-1075 Research Collaboration Agreement 10/17/2018] 10/17/2021] University of Pennsylvania School of Medicine Jeffrey Cohen 2018-1089 CRADA 8/26/2019] 8/26/2025|Terraimmune, Inc. [US] Ethan Shevach 2018-1125 CTA - Clinical Trial Agreement 10/2/2018 MAPP BIOPHARMACEUTICAL, INC. Richard Davey 2018-1136 CTA - Clinical Trial Agreement 11/27/2018 Gilead Sciences, Inc Richard Davey 2018-1146 CRADA 8/7/2019] _2/15/2022|CureVac AG [DE] 2018-1146 CRADA 8/7/2019] _2/15/2022|CureVac AG [DE] Columbia University (incl Columbia Technology 2018-1147 Research Collaboration Agreement 3/5/2019} 3/5/2021] Ventures) Ronald Germain Ministry of Health (MOH) of Democratic Republic 2018-1193 Letter of Intent/MOU 6/28/2019] 6/28/2024]of Congo (DRC) [CD] H Clifford Lane National Institute of Biomedical Research (INRB, 2018-1199 CTA - Clinical Trial Agreement 11/22/2018 Institut National de la Recherche Bio) [CD] H Clifford Lane United States Army Medical Research Institute of 2018-1220 Research Collaboration Agreement 10/10/2018] 10/10/2021) Infectious Diseases (USAMRIID) Peter Jahrling